Indianapolis, IN, United States of America

Patricia J Solenberg


Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1988-2008

Loading Chart...
17 patents (USPTO):Explore Patents

Title: Patricia J Solenberg: Innovator in Glycosyltransferase Enzymes

Introduction

Patricia J Solenberg is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of biotechnology, particularly in the area of glycosyltransferase enzymes. With a total of 17 patents to her name, her work has had a substantial impact on the development of new methods for producing glycopeptide compounds.

Latest Patents

Among her latest patents, one notable invention provides isolated nucleic acid compounds encoding a glycosyltransferase enzyme. This invention also includes vectors carrying genes that encode the enzyme, transformed heterologous host cells for expressing the enzyme, and methods for producing glycopeptide compounds using the cloned genes. Another significant patent involves the glycosyltransferase gene gtfE from Amycolatopsis orientalis, which similarly focuses on isolated nucleic acid compounds and their applications in biotechnology.

Career Highlights

Patricia is currently associated with Eli Lilly and Company, where she continues to advance her research and innovations. Her work at Eli Lilly has positioned her as a key player in the development of biopharmaceuticals, contributing to the company's reputation for excellence in the industry.

Collaborations

Throughout her career, Patricia has collaborated with notable colleagues, including Richard H Baltz and Patti J Treadway. These collaborations have further enriched her research and expanded the scope of her inventions.

Conclusion

Patricia J Solenberg's contributions to the field of biotechnology, particularly in glycosyltransferase enzymes, highlight her innovative spirit and dedication to advancing scientific knowledge. Her work continues to influence the development of new therapeutic methods and compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…